All data are based on the daily closing price as of May 19, 2025
p

Panion & Bf Biotech

1760.TW
2.59 USD
-0.01
-0.38%

Overview

Last close
2.59 usd
Market cap
222.42M usd
52 week high
3.82 usd
52 week low
2.43 usd
Target price
3.28 usd

Valuation

P/E
76.7797
Forward P/E
N/A
Price/Sales
3.5925
Price/Book Value
3.8925
Enterprise Value
231.13M usd
EV/Revenue
3.7239
EV/EBITDA
19.1046

Key financials

Revenue TTM
61.26M usd
Gross Profit TTM
27.81M usd
EBITDA TTM
10.24M usd
Earnings per Share
0.04 usd
Dividend
N/A usd
Total assets
98.88M usd
Net debt
8.15M usd

About

Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, and health care products in Taiwan, the United States, China, Hong Kong, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, Covid-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment, prevention, and veterinary products. It also offers nephrology, dermatology, pain management, hospital and household sanitization, and personal hygiene services. Panion & Bf Biotech Inc. was founded in 1974 and is headquartered in Taipei, Taiwan.
  • Symbol
    1760.TW
  • Exchange
    TW
  • Isin
    TW0001760007
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Biotechnology
  • CEO
  • Headquarter
    Taipei
  • Web site
    https://www.pbf.com.tw
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top